Speaker Program Limits Are Specific To Novartis Settlement

By Meena Datta, Whitney Nebolisa and Beth Hardcastle · August 17, 2020, 6:09 PM EDT

Much has been written about the recent settlement between Novartis Pharmaceuticals Corp. and the U.S. Department of Justice that resolves allegations of misconduct relating to in-person speaker programs held by the...

To view the full article, register now.